Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Leichner

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Dosimetry and treatment planning in radioimmunotherapyP K Leichner, N C Yang, B W Wessels, et al.
Cancer Treatment Reports|February 1, 1982
Phase I-II study of isotopic immunoglobulin therapy for primary liver cancerD S Ettinger, S E Order, M D Wharam, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1991
Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01G B Stillwagon, S E Order, C Guse, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group StudyG B Stillwagon, S E Order, C Guse, et al.
Journal of Computer Assisted Tomography|November 1, 1992
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonographyA Rahmouni, A Yang, C M Tempany, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1986
Radiolabeled antibody in the treatment of primary and metastatic liver malignanciesS E Order, J L Klein, P K Leichner, et al.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)|October 1, 1994
Induction of high grade astrocytoma (HGA) by protons: molecular mechanisms and RBE considerationsG V Dalrymple, P K Leichner, K A Harrison, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1988
Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatomaP K Leichner, N C Yang, T L Frenkel, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1981
Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetryP K Leichner, J L Klein, J B Garrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01H M Vriesendorp, J M Herpst, M A Germack, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Dosimetry and treatment planning in radioimmunotherapyP K Leichner, N C Yang, B W Wessels, et al.
Cancer Treatment Reports|February 1, 1982
Phase I-II study of isotopic immunoglobulin therapy for primary liver cancerD S Ettinger, S E Order, M D Wharam, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1991
Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01G B Stillwagon, S E Order, C Guse, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: a Radiation Therapy Oncology Group StudyG B Stillwagon, S E Order, C Guse, et al.
Journal of Computer Assisted Tomography|November 1, 1992
Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonographyA Rahmouni, A Yang, C M Tempany, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1986
Radiolabeled antibody in the treatment of primary and metastatic liver malignanciesS E Order, J L Klein, P K Leichner, et al.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)|October 1, 1994
Induction of high grade astrocytoma (HGA) by protons: molecular mechanisms and RBE considerationsG V Dalrymple, P K Leichner, K A Harrison, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1988
Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatomaP K Leichner, N C Yang, T L Frenkel, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1981
Dosimetry of 131I-labeled anti-ferritin in hepatoma: a model for radioimmunoglobulin dosimetryP K Leichner, J L Klein, J B Garrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01H M Vriesendorp, J M Herpst, M A Germack, et al.
Pageof 6